Stanford University Hospital
Palo Alto, California, 94305, United States
Location status: Recruiting
NCT Number: NCT06880341
The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Collect data on all interventions and assessments performed during the recovery post surgery up to 30 days, to understand what factors might cause Transient Neurologic Events (TNEs) and determine how these can be reduced in Moyamoya subjects post surgery.
Interested in participating?
Request Info3 year and older
All sexes
Observational
Palo Alto, California, 94305, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard of care treatment of Transient Neurologic Events (TNEs) as needed
Time frame: 30 days post-surgery
Number of Incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales (e.g., NIH Stroke Scale, Modified Rankin Scale), binned by week.
Contact information is provided by the study sponsor or research team.
Stanford University
Other
MagNETs- Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease
Acronym: MagNETs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06935578
Arterial Occlusive Diseases, Brain Diseases
Acquaviva delle Fonti, BA, Italy
View Trial DetailsNCT05785598
Arterial Occlusive Diseases, Brain Diseases
Paris, France
View Trial DetailsNCT07711457
Arterial Occlusive Diseases, Augmented Reality
Taipei, Taiwan
View Trial DetailsNCT07377695
Arterial Occlusive Diseases, Brain Diseases
Seongnam-si, Gyeonggi-do, South Korea
View Trial Details